Loading...
XNAS
PODD
Market cap21bUSD
Dec 05, Last price  
304.49USD
1D
-3.62%
1Q
-12.61%
Jan 2017
708.09%
IPO
1,870.81%
Name

Insulet Corp

Chart & Performance

D1W1MN
XNAS:PODD chart
P/E
51.21
P/S
10.34
EPS
5.95
Div Yield, %
—
Shrs. gr., 5y
3.47%
Rev. gr., 5y
22.92%
Revenues
2.07b
+22.07%
50,0003,663,00013,372,00036,059,00066,032,00096,966,000152,255,000211,369,000247,084,000288,720,000263,893,000366,989,000463,768,000563,823,000738,200,000904,400,0001,098,800,0001,305,300,0001,697,100,0002,071,600,000
Net income
418m
+102.76%
-21,636,000-35,950,000-53,539,000-92,791,000-79,541,000-61,159,000-57,170,000-51,867,000-44,974,000-51,500,000-73,520,000-28,879,000-26,831,0003,292,00011,600,0006,800,00016,800,0004,600,000206,300,000418,300,000
CFO
430m
+195.33%
-20,321,000-31,820,000-50,372,000-82,611,000-49,323,000-35,625,000-25,452,000-29,059,0003,348,0008,920,000-12,552,00015,911,00041,207,00035,899,00098,400,00084,000,000-68,100,000119,000,000145,700,000430,300,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
URL
https://www.omnipod.com/
IPO date
May 15, 2007
Employees
2,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT